Seems to me that Mr. Ehrlich, receiving an email from someone just registered on this board, would be unlikely to respond to such an email as sent and if he did respond it surely seems it would have been with an EXTREMELY generic statement such as "management continues to work in the best interest of shareholders". Any other claim does not stand up to scrutiny IMO.
(1)
(0)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links